Kevin Byrne
No Rating Available
(Learn About Our Rating System)

Kevin Byrne, MD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

1950 Circle of Hope
Salt Lake City , UT 84112
Get Directions

Kevin Byrne, MD, Assistant Professor (Clinical), earned his medical degree at Boston University School of Medicine. He completed Adult Psychiatry residency at the University of Utah Spencer Fox Eccles School of Medicine where he served as Chief Resident. He is board certified in Psychiatry by the ABPN. Dr. Byrne's clinical interests include psychiatric care for people with cancer, existential distress, psychedelic treatments for mental health, treatment-resistant mood disorders, trauma and its related conditions, and advanced psychopharmacology. His research focuses on examining psychedelic treatments such as ketamine, MDMA, and psilocybin for the treatment of existential distress and other mental health conditions. Dr. Byrne is excited to be continuing his work as a member of the outpatient teams at the University of Utah Huntsman Mental Health Institute and at the Huntsman Cancer Hospital.

Specialties

Board Certification

American Board of Psychiatry & Neurology (Psychiatry)

Kevin Byrne, MD, Assistant Professor (Clinical), earned his medical degree at Boston University School of Medicine. He completed Adult Psychiatry residency at the University of Utah Spencer Fox Eccles School of Medicine where he served as Chief Resident. He is board certified in Psychiatry by the ABPN. Dr. Byrne's clinical interests include psychiatric care for people with cancer, existential distress, psychedelic treatments for mental health, treatment-resistant mood disorders, trauma and its related conditions, and advanced psychopharmacology. His research focuses on examining psychedelic treatments such as ketamine, MDMA, and psilocybin for the treatment of existential distress and other mental health conditions. Dr. Byrne is excited to be continuing his work as a member of the outpatient teams at the University of Utah Huntsman Mental Health Institute and at the Huntsman Cancer Hospital.

Board Certification and Academic Information

Academic Departments Psychiatry -Assistant Professor (Clinical)
Academic Divisions Adult Psychiatry
Board Certification
American Board of Psychiatry & Neurology (Psychiatry)

Education history

Undergraduate Computer Science - Pomona College B.A.
Professional Medical Medicine - Boston University School of Medicine M.D.
Residency Adult Psychiatry - University of Utah Spencer Fox Eccles School of Medicine Resident
Residency Adult Psychiatry - University of Utah Spencer Fox Eccles School of Medicine Chief Resident

Selected Publications

Journal Article

  1. Lewis BR, Reid MJ, Novick AM, Byrne K, Niciu MJ, Fonzo GA, Meyer TD, Feifel D, El-Mallakh RS, Soares J, Suppes T, Barrett F (2026). Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compounds. Journal of psychopharmacology (Oxford, England), Epub ahead of print.
  2. Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland E (2025). Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial. PLoS medicine, 22(9), e1004519.
  3. Byrne KJ, Lindsay S, Baker N, Schmutz C, Lewis (2023). In naturalistic psychedelic use, group use is common and acceptable. Journal of psychedelic studies,
  4. Lewis BR, Byrne K, Hendrick J, Garland EL, Thielking P, Beck (2023). Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial. Journal of psychedelic studies,
  5. Lewis BR, Garland EL, Byrne K, Durns T, Hendrick J, Beck A, Thielking (2023). HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer. Journal of pain and symptom management, 66(3), 258-269.
  6. Turner DC, Edmiston AM, Zohner YE, Byrne KJ, Seigfreid WP, Girkin CA, Morris JS, Downs JC (2019). Transient Intraocular Pressure Fluctuations: Source, Magnitude, Frequency, and Associated Mechanical Energy. Invest Ophthalmol Vis Sci, 60(7), 2572-2582.
  7. Keefe KR, Byrne KJ, Levi JR (2018). Treating pediatric post-tonsillectomy pain and nausea with complementary and alternative medicine. Laryngoscope, 128(11), 2625-2634.
  8. Fowler ML, Zhu C, Byrne K, Lieber SB, Moore A, Shmerling RH, Paz Z (2017). Pathogen or contaminant? Distinguishing true infection from synovial fluid culture contamination in patients with suspected septic arthritis. Infection, 45(6), 825-830.

Review

  1. Lewis BR, Byrne (2023). A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder. Focus (American Psychiatric Publishing), 21(3), 247-256.
  2. Lewis BR, Byrne (2021). Is MDD the right target for early-stage psychedelic-assisted therapy trials?. Journal of psychedelic studies, 5(2), 65-68.

Commentary

  1. Lewis BR, Byrne KJ, Beck (2023). Group Format Psilocybin-Assisted Therapy: Commentary on the HOPE trial (HOPE: a pilot study of psilocybin-enhanced group psychotherapy in patients with cancer) . Journal of Anesthesiology and Pain Therapy, 4(3), 1-3.

News & Podcasts

News

Schedule Online